Hematologic Malignancy
Alkylating Agent-Related Acute Myeloid Leukemia
CI-CAN-00004428Explore in graph →
Hematologic1 active trials
- NCIt
- C27754
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00004428Explore in graph →
Rankings
1 current ranking rows (latest year per scope). Each row lists the scope, the formula version, the value and the exact inputs that produced it.
| Metric | Scope | Rank / eligible | Δ | Value | Percentile | Confidence | Formula | Generated | Inputs |
|---|---|---|---|---|---|---|---|---|---|
| Active clinical trials | World · both sexes · all ages · latest · all malignant entities | #1186 / 1,654 | = | 1 count | 28.3 | Medium confidence | ci-active-trials-v1 | Sep 30, 2026 | showformula: COUNT(DISTINCT trial) FROM trial_conditions JOIN clinical_trials WHERE cancer_id IN descendants(cancer) AND study_type = INTERVENTIONAL AND overall_status IN (RECRUITING, NOT_YET_RECRUITING, ENROLLING_BY_INVITATION, ACTIVE_NOT_RECRUITING)
inputs hash d8f333d5bfdbadb41c05f9e2 Trace lineage (admin) |
Computed Ranks are competition ranks (ties share a rank). Percentile = share of eligible entities ranked at or below this one in the ranking direction.
"Deadliest" is ambiguous: annual deaths, age-standardized mortality rate, mortality-to-incidence ratio and 5-year survival rank cancers differently. CancerIndex publishes each as a separate metric.
Unmet need · computed
No research-gap components for this entity